Can you detect colon cancer without a colonoscopy?
Colorectal cancer is a significant public health concern, with thousands of new cases diagnosed each year. While a colonoscopy remains the gold standard for detecting and preventing this disease, many individuals are hesitant to undergo this invasive procedure due to uncomfortable side effects and the need for sedation. Fortunately, there are alternative screening options available that can help identify the early signs of colorectal cancer without the need for a colonoscopy. In this article, we’ll explore the various non-invasive testing methods, their benefits, and limitations, to empower you to make an informed decision about your colorectal cancer screening.
Understanding colorectal cancer
Colorectal cancer, also known as colon cancer or rectal cancer, is a type of cancer that originates in the large intestine (colon) or the rectum. It typically develops from precancerous growths called polyps, which can slowly turn into cancerous tumours over time. Early detection is crucial, as colorectal cancer is highly treatable when caught early, but can become more challenging to manage as it progresses.
Key statistics on colorectal cancer
- Colorectal cancer is the third most common cancer in the United States, with an estimated 149,500 new cases expected in 2023
- It is the second leading cause of cancer-related deaths in the United States, with an estimated 52,550 deaths expected in 2023
- The average lifetime risk of developing colorectal cancer is about 1 in 23 (4.3%) for men and 1 in 25 (4%) for women
Screening options beyond colonoscopy
While a colonoscopy is considered the gold standard for colorectal cancer screening, several alternative testing methods can be used to detect the early signs of the disease. These non-invasive options offer various benefits, including convenience, reduced preparation requirements, and the ability to be performed at home.
Blood tests
Blood-based tests, such as the Epi proColon and Shield tests, are designed to detect specific DNA changes or proteins associated with colorectal cancer. These tests involve a simple blood draw and can be performed in a healthcare setting. They do not require any bowel preparation or dietary restrictions, making them a more convenient option for some individuals.
Key considerations for blood-based tests:
- They can detect the presence of colorectal cancer but may miss some precancerous polyps or early-stage cancers
- If the test results are abnormal, a follow-up colonoscopy will still be necessary to investigate the findings further
- Insurance coverage and out-of-pocket costs may vary for these tests, so it’s important to check with your healthcare provider and insurance provider
Stool tests
Stool-based tests, such as the faecal immunochemical test (FIT) and the multitargeted stool DNA test (MT-sDNA or Cologuard), analyse your stool sample for signs of colorectal cancer or precancerous polyps. These tests can be completed at home, with the sample collected and sent to a laboratory for analysis.
Key considerations for stool tests:
- FIT and MT-sDNA tests are less invasive than a colonoscopy and can be done more frequently (annually or every 3 years, respectively)
- They can detect the presence of blood or abnormal DNA in the stool, which may indicate the presence of cancer or precancerous polyps
- If the test results are positive, a follow-up colonoscopy will still be necessary to investigate the findings further
- FIT tests may have a higher rate of false-positive results, meaning the test may indicate the presence of cancer or polyps when they are not present
Virtual colonoscopy (CT colonography)
Virtual colonoscopy, also known as CT colonography, is a non-invasive imaging test that uses a CT scan to create detailed images of the colon and rectum. This procedure does not require the insertion of a scope, but it does require the same bowel preparation as a traditional colonoscopy.
Key considerations for virtual colonoscopy:
- It can provide a comprehensive view of the entire colon, similar to a traditional colonoscopy
- If any abnormalities are detected, a follow-up colonoscopy may still be necessary to further investigate or remove any polyps or growths
- Virtual colonoscopy exposes the patient to a small amount of radiation, which may be a concern for some individuals
- The procedure may not be as effective at detecting small polyps or flat lesions compared to a traditional colonoscopy
- Sigmoidoscopy
A flexible sigmoidoscopy is a procedure that allows the healthcare provider to examine the lower part of the colon (the rectum and sigmoid colon) using a flexible tube. This test is less invasive than a full colonoscopy, as it only examines a portion of the colon.
Key considerations for sigmoidoscopy:
- It can detect polyps or cancerous growths in the lower part of the colon but may miss lesions in the upper part of the colon
- Sigmoidoscopy is not as widely used for colon cancer screening in the United States, as it does not provide a comprehensive view of the entire colon
- If any abnormalities are detected during a sigmoidoscopy, a follow-up colonoscopy may still be necessary
- The procedure typically requires some bowel preparation but is not as extensive as the preparation for a full colonoscopy
Factors to consider when choosing a screening test
When selecting a colorectal cancer screening test, there are several factors to consider, including your personal preferences, risk factors, and the recommendations of your healthcare provider.
Preparation and convenience
Some screening tests, such as colonoscopy and virtual colonoscopy, require extensive bowel preparation, which can be inconvenient and uncomfortable for some individuals. Stool tests and blood tests, on the other hand, often have fewer preparation requirements, making them a more convenient option for many people.
Frequency of testing
Colonoscopy is typically recommended every 10 years for individuals at average risk, while other tests, such as FIT and MT-sDNA, may need to be performed more frequently (annually or every 3 years, respectively). The frequency of testing can be an important consideration when choosing a screening method.
Sensitivity and accuracy
Colonoscopy is generally considered the most sensitive and accurate screening test for detecting colorectal cancer and precancerous polyps. However, other tests, such as blood-based and stool-based tests, may have a higher rate of false-positive or false-negative results, which can lead to the need for additional testing or unnecessary worry.
Personal and family history
Your risk factors, such as a personal or family history of colorectal cancer or precancerous polyps, may influence the screening recommendations made by your healthcare provider. In some cases, they may suggest more frequent or specialised testing, regardless of the screening method chosen.
Cost and insurance coverage
The cost of colorectal cancer screening tests can vary, and insurance coverage may differ depending on the specific test and your healthcare plan. It’s important to discuss the financial implications with your healthcare provider and insurance provider to ensure that the chosen screening method is both effective and affordable for your situation.
Choosing the right screening test for you
Ultimately, the decision of which colorectal cancer screening test to choose should be made in consultation with your healthcare provider. They can help you weigh the pros and cons of each option, considering your personal preferences, risk factors, and the recommendations of leading medical organisations.
Remember, the most important thing is to get screened regularly, regardless of the specific test you choose. Early detection can greatly improve your chances of successful treatment and a positive health outcome.
Staying vigilant and proactive
In addition to regular colorectal cancer screening, it’s important to be aware of the signs and symptoms of the disease and to report any changes in your bowel habits or other concerning symptoms to your healthcare provider. Maintaining a healthy lifestyle, including a nutritious diet and regular exercise, can also help reduce your risk of developing colorectal cancer.
Conclusion
The ability to detect colorectal cancer without a colonoscopy is a significant advancement in the field of cancer screening. By understanding the various non-invasive testing options available, you can make an informed decision about the screening method that best fits your needs and preferences. Remember, the key to successful colorectal cancer prevention and early detection is to stay proactive and work closely with your healthcare provider to develop a screening plan.
Sources
- Weighing the options – Mayo Clinic
- Colorectal Cancer Screening Tests | Sigmoidoscopy & Colonoscopy – American Cancer Society
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Related Articles
WHY WE BUILT NOWPATIENT
We are committed to helping everyone, everywhere live healthier lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For your peace of mind, we can answer your questions quickly
What does NowPatient do?
NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.
Get started today and benefit from medication reminders, Get Treated Privately, NHS online pharmacy, GP appointment booking, Rx savings card, Drug Coupons, US drug savings programs, health conditions information, genetic testing, home test kits, BMI Risks, Type 2 Diabetes Risks, pollen meter, air quality monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.
UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.
US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
We do not provide any prescribing services or dispensing services in the United States.
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111